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ABSTRACT
Background The small intestinal epithelium is highly
sensitive to radiation and is a major site of injury during
radiation therapy and environmental overexposure.
Objective To examine probiotic bacteria as potential
radioprotective agents in the intestine.
Methods 8-week-old C57BL/6 wild-type or knockout
mice were administered probiotic by gavage for 3 days
before 12 Gy whole body radiation. The intestine was
evaluated for cell-positional apoptosis (6 h) and crypt
survival (84 h).
Results Gavage of 5310
7 Lactobacillus rhamnosus GG
(LGG) improved crypt survival about twofold (p<0.01);
the effect was observed when administered before, but
not after, radiation. Conditioned medium (CM) from LGG
improved crypt survival (1.95-fold, p<0.01), and both
LGG and LGG-CM reduced epithelial apoptosis
particularly at the crypt base (33% to 18%, p<0.01).
LGG was detected in the distal ileal contents after the
gavage cycle, but did not lead to a detectable shift in
bacterial family composition. The reduction in epithelial
apoptosis and improved crypt survival offered by LGG
was lost in MyD88
 / , TLR-2
 /  and cyclo-oxygenase-
2
 /  (COX-2) mice but not TLR-4
 /  mice. LGG
administration did not lead to increased jejunal COX-2
mRNA or prostaglandin E2 levels or a change in number
of COX-2-expressing cells. However, a location shift was
observed in constitutively COX-2-expressing cells of the
lamina propria from the villi to a position near the crypt
base (villi to crypt ratio 80:20 for control and 62:38 for
LGG; p<0.001). Co-staining revealed these COX-2-
expressing small intestinal lamina propria cells to be
mesenchymal stem cells.
Conclusions LGG or its CM reduce radiation-induced
epithelial injury and improve crypt survival. A TLR-2/
MyD88 signalling mechanism leading to repositioning of
constitutive COX-2-expressing mesenchymal stem cells
to the crypt base is invoked.
INTRODUCTION
The small intestine epithelium and the bone
marrow are highly sensitive to radiation and are the
major sites of injury during radiation therapy.
1 2
Diarrhoea induced by radiation of the small intes-
tine is the limiting factor in the dosing of radiation
therapy for rectal cancer and other abdominal
malignancies.
3 There is a need for agents that could
be given before radiation therapy that would
diminish radiation injury to the small intestine
without decreasing the radiation sensitivity of the
tumour.
Interactions between the commensal bacteria and
the epithelium inﬂuence the epithelial response to
injury. Signalling through TLRs affects epithelial
proliferation in the dextran sulphate sodium (DSS)
model of colitis,
4e7 and microbial interactions affect
the host’s response to radiation.
89Bacterial products
can affect the intestinal epithelial response to
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Signiﬁcance of this study
What is already known about this subject?
< In radiotherapy for abdominal malignancy,
radiation-induced diarrhoea from collateral
small bowel epithelial injury is a dose-limiting
side effect.
< Lipopolysaccharide and ﬂagellin, TLR-4 and TLR-
5 ligands, have been demonstrated to be
radioprotective in the small intestine.
< Radioprotection induced by parenteral lipopoly-
saccharide is cyclo-oxygenase-2 (COX-2)
dependent.
What are the new ﬁndings?
< Orally administered Lactobacillus rhamnosus GG
(LGG) probiotic and its conditioned medium
protect the murine small intestinal epithelium
from radiation injury.
< LGG-mediated radioprotection is dependent on
MyD88, TLR-2 and COX-2 and occurs without
signiﬁcantly altering the bacterial family compo-
sition of the small intestine.
< Administration of LGG does not change COX-2
levels, but results in a repositioning of COX-2-
expressing mesenchymal stem cells of the
lamina propria from the villi to the crypt region.
How might it impact on clinical practice in the
foreseeable future?
< This study raises the possibility that LGG, other
probiotic bacteria, or probiotic-derived products
may be useful as a prophylactic strategy to limit
intestinal injury to humans during radiation
therapy.
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Probioticsradiation injury. Lipopolysaccharide (LPS), a TLR-4 ligand, is
radioprotective in the mouse intestine through a mechanism that
involves prostaglandin E2 (PGE2) synthesis through cyclo-
oxygenase-2 (COX-2).
10 Administration of TLR-5 ligands, ﬂagellin
or CBL13502 (a polypeptide drug derived from salmonella
ﬂagellin) before irradiation protected both mice and monkeys
from gastrointestinal (GI) and haematopoietic acute radiation
syndromes.
11e13
Probiotic therapies have been clinically evaluated and used as
treatment for human inﬂammatory bowel diseases, pouchitis,
irritable bowel syndrome and antibiotic-associated diar-
rhoea.
14e16 For inﬂammatory bowel diseases, most probiotic
studies have been largely descriptive, although recent investi-
gations in mice describe anti-apoptotic and anti-inﬂammatory
mechanisms for the probiotic, Lactobacillus rhamnosus GG
(LGG).
17 18
There have been preliminary studies of probiotic use in the
prevention or treatment of radiation injury in the intestine.
19 In
experimental models of radiation injury, lactobacillus or
a mixture of lactobacillus and biﬁdobacterium given to rodents
before and after radiation resulted in improved histology
20 and
decreased endotoxaemia and sepsis.
21 22 No assessment was
made of epithelial crypt survival or apoptosis, nor was any
mechanism described. In humans, probiotics have been used to
control diarrhoea after radiation exposure has begun, showing
a trend towards beneﬁt.
23e25 Treatment with a probiotic
combination of Lactobacillus acidophilus plus Biﬁdobacterium
biﬁdum was compared with placebo in patients receiving radia-
tion therapy with weekly cisplatin for cervical cancer.
26 The
combination of probiotics resulted in less diarrhoea. Since
radiotherapy is a planned event and prophylactic therapy is
feasible, we sought to determine if prophylactic probiotic
treatment affects the intestinal epithelial response to radiation
as assessed by apoptosis and crypt survival.
METHODS AND MATERIALS
Mice
All mice used were on the C57Bl/6 background. Wild-type (WT),
TLR-2
 /  and TLR-4
 /  mice were purchased from Jackson
Laboratories (Bar Harbour, Maine, USA) and bred in house.
MyD88
 / and COX-2
 /  mice are maintained in our facility as
previously described.
4 Experiments with WT mice were
conﬁrmed both on those purchased directly from Jackson
Laboratories and those bred in house. Comparator groups were
matched for age and sex, typically as littermates. Female mice
were preferentially used. WT mice (phosphate-buffered saline
(PBS) vs LGG treated) were tested concurrently as positive
controls with all knockout mouse experiments. All mice were
maintained on a 12 h light/dark schedule in a temperature-
controlled speciﬁc pathogen free facility and fed standard labo-
ratory mouse chow. Animal procedures and protocols were
conducted in accordance with the institutional review board at
Washington University School of Medicine. Whole body irradi-
ation of mice was carried out in a Gammacell 40 137Cs irradiator
(Atomic Energy of Canada Ltd, Chalk River, Ontario, Canada) at
a dose rate of 80.7 cGy/min and a total dose of 12 Gy.
Apoptosis and crypt survival in mouse small intestine
After 12 Gy whole body irradiation, mice were killed at 6 h
(apoptosis studies) or 84 h (crypt survival studies). The entire
small intestine was harvested and used to collect tissue for RNA
or protein determination or histology. The proximal jejunum and
distal ileum were ﬁxed for histology in 10% formalin with PBS. A
minimum of six 5 mm segments were taken from each mouse and
parafﬁn embedded for analysis. Apoptosis was scored on a cell-
positional basis by light microscopic analysis (H&E and TUNEL
(terminal deoxynucleotidyl transferase dUTP nick end labeling))
of 100 half-crypt sections per mouse with at least four mice in
each group.
27 All crypts chosen were at least 20 cells in height,
with cell position 1 located at the crypt base. Crypt survival was
measured as described previously using a modiﬁcation of the
microcolony assay.
10 28 For these experiments, 120 mg/kg
bromodeoxyuridine (BrdU, Sigma) and 12 mg/kg ﬂuorodeoxyur-
idine (Sigma) was injected 90 min before death to label S-phase
cells identiﬁed by immunohistochemistry. The viability of
a surviving crypt was conﬁrmed by incorporation of BrdU into
ﬁve or more epithelial cells within each regenerative crypt.
Probiotics and conditioned medium
Lactobacillus spp. were purchased from American Tissue Culture
Collection (ATCC, Manassas, Virginia, USA). Lactobacillus
rhamnosus GG (LGG) (ATCC 53103), Lactobacillus acidophilus
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Figure 1 Radiation-induced epithelial apoptosis is suppressed by
Lactobacillus rhamnosus GG (LGG) and LGG conditioned medium
(LGG-CM). C57/B6 mice (8e10 weeks old) received gavage with
phosphate-buffered saline (PBS) (control), LGG (5310
7) or LGG-CM for
3 days before exposure to 12 Gy of whole body gamma radiation.
(A) Cell position distribution of apoptotic epithelial cells was determined
on H&E and TUNEL (terminal deoxynucleotidyl transferase dUTP nick
end labeling). stained slides in 100 proximal jejunal half-crypt sections
per mouse (n¼6/group) and expressed as the apoptotic index. The
apoptotic index was signiﬁcantly lower in mice pretreated with LGG or
LGG-CM versus controls (p<0.01 at all cell positions 3e12). This
protected region included the putative stem cell domain (position 4e5).
(B) Representative images from the jejunum are shown with arrows
pointing to apoptotic cells (2003).
830 Gut 2012;61:829e838. doi:10.1136/gutjnl-2011-300367
Probiotics(ATCC 393) and Lactobacillus casei (ATCC 4356) were cultured
according to the manufacturer’s recommendations in MRS
broth (Fisher Scientiﬁc, Pittsburg, Pennsylvania, USA). Bacteria
were cultured at 378C to reach log phase growth as determined
by a 0.5 A600 reading,
29 then immediately centrifuged at 12003g
for 10 min and washed twice with cold PBS. Bacteria were
brought up in volumes to reach the desired number of bacteria
per 200 ml for murine gavage. Concentrations of live bacteria
were conﬁrmed by serial dilutions and plating for colony
forming unit counts. Commercially marketed forms of the
probiotic supplements LGG (Culturelle; Ameriﬁt, Cromwell,
Connecticut, USA) and Biﬁdobacterium infantis 35624 (Proctor &
Gamble, Cincinnati, Ohio, USA) were tested separately.
Heat-killed bacteria were prepared as previously described
exposing LGG in PBS to boiling temperature for 30 min followed
by a PBS wash.
30 LGG conditioned culture medium (LGG-CM)
was prepared by growing LGG in MRS broth to log phase
growth. The cultured broth was then centrifuged (15003g for
10 min) to pellet the majority of bacteria before allowing the
culture to again reach log phase growth. After a second centri-
fugation, the CM pH was adjusted to that of freshly prepared
control MRS broth. Both preparations were sterile ﬁltered
(0.2 mm) before use.
Organ-speciﬁc mesenchymal stem cells (MSCs)
Small intestinal and colon MSCs were prepared as previously
described.
31 In vitro stimulation of MSCs was performed with
a commercial TLR-2 ligand (Pam3CSK4, catalogue number
Tlr1-pms; Invivogen, San Diego, California, USA) at the
concentrations described.
Protein and nucleic acid analysis
Whole tissue RNA expression was analysed by quantitative
reverse transcription (qRT)-PCR as previously described.
32 33
qRT-PCR primer sequences are described in online supplemen-
tary table 1. Formalin-ﬁxed parafﬁn-embedded jejunal tissues
were used for immunoﬂuorescence using high-temperature
citrate-based antigen retrieval. COX-2-expressing cells were
detected using a mouse monoclonal antibody (BD Biosciences,
San Diego, California, USA; catalogue number 610204; diluted
1:50) followed by AlexaFluor 594 goat anti-mouse (Molecular
Probes, Carlsbad, California, USA; catalogue number 11032;
diluted 1:250). The surfaces of epithelial cells were labelled using
rabbit anti-human b-catenin (Santa Cruz Biotechnology, Santa
Cruz, California, USA; catalogue number sc-7199; diluted 1:100)
followed by AlexaFluor 488 donkey anti-rabbit (Molecular
Probes; catalogue number 21206; diluted 1:250). Photomicro-
graphs were taken at 2003 magniﬁcation and used to obtain
counts of COX-2-expressing stromal cells in the crypt and villus
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Figure 2 Crypt survival after radiation is improved by live Lactobacillus
probiotics and Lactobacillus rhamnosus GG (LGG) culture medium
supernatant (LGG-CM). Mice were gavaged with probiotic species
described or LGG-CM for 3 days before radiation (IR) with 12 Gy. Eighty-
four hours after radiation exposure, mice were injected with
bromodeoxyuridine (BrdU). Intestinal tissues were harvested 90 min
later and ﬁxed for BrdU staining. (A) A representative jejunal cross-
section from an untreated mouse is compared with sections from mice
exposed to radiation which received pretreatment with either phosphate-
buffered saline (PBS) (control) or LGG. (B) Dose ﬁnding comparison
showed no additional beneﬁt at bacterial loads over 1310
8, with a dose
of 5310
7 being used for subsequent experiments. *p<0.05 and
**p<0.01 vs PBS; # no signiﬁcant difference between groups. (C)
Three different Lactobacillus spp. were evaluated and the mean gain in
jejunal regenerative crypts is shown. *p<0.05 and **p<0.01 vs PBS.
(D) The number of regenerative crypts for each listed treatment group is
shown for the proximal jejunum and distal ileum (mean+SEM, n$8
mice/group, $2 experiments). *p<0.05 and **p<0.01 vs PBS.
(Continued)
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Probioticsregions. At this magniﬁcation, each picture covered a length of
340 mm. Data are the mean number of cells per picture (340 mm
length) for 20 locations along the lengths of the jejunal tissue
sections from ﬁve mice. This encompassed >800 COX-2-
expressing cells in more than 120 crypt/villus structures. The
PGE2 assay was performed as previously described
33 using an
ELISA (Cayman Chemical, Ann Arbor, Michigan, USA; cata-
logue number 514010) according to the manufacturer’s protocol.
Flow cytometry was also performed as previously described
with identical antibodies.
31
To evaluate the effect that LGG gavage has on small intestinal
bacterial composition, we used a genomic DNA-based approach
as previously described.
34 A complete methodological descrip-
tion is available in supplementary information online. Brieﬂy,
ileal contents and mucosal scrapings were obtained from groups
of mice 12 h after the last of three gavages with PBS or live
washed LGG in PBS. Bacterial DNA concentrations were esti-
mated by quantitative PCR (qPCR) assays using validated
primers targeting total bacteria (rpoB) and family-speciﬁc
primers targeting 16S rRNA.
35 For quantiﬁcation of LGG,
a qPCR assay was standardised using validated strain-speciﬁc
primers.
36 37
Statistical analysis
The two-sided, non-paired Student t test was used for
most comparisons between treatment and control groups
including crypt survival, positional apoptosis, bacterial concen-
trations, and weight loss by day. Survival data were assessed
using the ManteleCox log rank test. Data are expressed as
mean6SEM unless otherwise noted. Prism GraphPad Software
(LaJolla, California, USA) was used for data analysis and
graph generation.
RESULTS
LGG and LGG-CM diminish radiation-induced apoptosis in
a position-dependent fashion
In WT mice, 12 Gy of radiation induced small intestinal epithelial
cell apoptosis in a position-dependent fashion (ﬁgure 1A).
Assessment of apoptosis by H&E or TUNEL assay gave equal
results (ﬁgure 1B). Six hours after irradiation, the apoptotic
index was >30% in positions 4e5 and fell off gradually to below
10% at position 12. Mice pretreated with LGG or LGG-CM
showed a signiﬁcant reduction in position-dependent apoptosis.
LGG and LGG-CM reduced apoptosis at position 4 from 33% to
17% and 20%, respectively. Position 4 is the position of the
purported quiescent epithelial stem cell.
38 The effects of LGG
and LGG-CM in the proximal jejunum were similar. There was
no signiﬁcant difference in the apoptotic index between control
groups gavaged with PBS or uncultured MRS medium (data for
MRS not shown). The radioprotection of LGG or LGG-CM was
apparent both in mice purchased from a commercial vendor and
those with lifetime exposure to our institutional housing
facility.
Lactobacillus probiotics and LGG-CM enhance intestinal crypt
survival
In the absence of radiation, there were about 120 crypts per
cross-jejunal section. Eighty-four hours after a single dose of
12 Gy radiation in WT mice there averaged 15 surviving crypts
per cross-section. Pretreatment with LGG increased the number
of surviving crypts approximately twofold (ﬁgure 2A). In
doseeresponse studies, LGG offered some protection at a dose of
1310
6 bacteria per treatment, with improved efﬁcacy at doses of
$1310
7 bacteria per treatment (ﬁgure 2B). Pretreatment with L
casei and L acidophilus also increased crypt survival (ﬁgure 2C).
Observed crypt survival was highest in the LGG group, although
the difference between Lactobacillus spp. was not signiﬁcant.
Pretreatment with LGG signiﬁcantly increased the number of
surviving crypts along the length of the small intestine, both in
the proximal jejunum and distal ileum (ﬁgure 2D). In contrast,
the administration of LGG after irradiation had no effect on the
number of surviving crypts. Pretreatment with LGG superna-
tant increased the number of surviving crypts from 15 to 29. In
contrast with the increase in crypt survival with live LGG or
with LGG-CM, there was no signiﬁcant increase in crypt
survival with heat-killed LGG. To determine if the effects of the
LGG supernatant could be active systemically as well as topi-
cally, LGG-CM was administered at equal dosing intraperito-
neally to mice before radiation. Although mice tolerated this
injection without adverse outcome, no beneﬁt to crypt survival
was observed (data not shown).
Administration of a commercially available LGG product
(Culturelle; 1/500th of a capsule dissolved in PBS) resulted in
a level of radioprotection similar to that produced by live
cultured LGG and signiﬁcantly greater than PBS control (table 1).
This beneﬁt was not offered with equal dosing of a non-
lactobacillus-containing commercially available probiotic (B
infantis 35624; Align), suggesting that Lactobacillus may be the
favoured probiotic genus for limiting radiation-induced small
intestinal injury.
LGG before radiation improves survival, diminishes weight loss,
and reduces intestinal crypt loss
Small intestinal epithelial damage and weight loss are compo-
nents of the radiation GI syndrome. Irradiated mice consistently
lost weight after irradiation, reaching 70% of their starting
weight by 7 days (ﬁgure 3A). Mice pretreated with LGG lost
weight for 5 days after irradiation and then began to regain their
lost weight before reaching a plateau and ultimately losing
weight again. In mice, death is a standard end point measured in
the study of acute GI radiation syndrome and typically occurs
within the ﬁrst 10 days after exposure.
1 In our experiments,
irradiated control mice began to die at 6 days after irradiation
and mortality was 100% by day 11 (ﬁgure 3B). In contrast, mice
pretreated with LGG began to die at 10 days after irradiation and
some survived to day 14. Death after day 10 is described as most
attributable to the combined effects of GI toxicity and bone
marrow failure. Histological examination at day 7, when the
greatest separation in weight curves was observed, revealed
a larger number of villi in LGG-pretreated mice than in irradiated
controls (ﬁgure 3C,D).
Table 1 Crypt survival after pretreatment with
probiotics
Treatment Crypt survival p Value
PBS control 1.0060.15
LGG (cultured/washed) 1.9860.23 <0.01
Culturelle 1.6460.13 0.01
Biﬁdobacterium infantis 35624 1.0960.18 0.37
Mice were given probiotics (LGG at 5310
8 bacteria, Culturelle and B
infantis at 1:500th capsule) for 3 days before irradiation with 12 Gy and
killed at 84 h after irradiation. Jejunal crypt survival was assessed by
bromodeoxyuridine incorporation. Mean6SEM crypt survival is
presented as normalised to PBS control. p Value is compared with PBS
control.
LGG, Lactobacillus rhamnosus GG; PBS, phosphate-buffered saline.
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ProbioticsLGG treatment and small intestinal microbial composition
Since change in commensal bacteria composition is a potential
mechanism by which probiotics exert their effect, we examined
the impact of LGG gavage on small intestinal microbial
composition using a genomic-based approach. As the biological
end point of improved epithelial crypt survival was identiﬁed in
the ileum, this intestinal segment was analysed using the
luminal contents and mucosal scrapings of mice treated with
PBS or LGG. No signiﬁcant changes were found in total bacteria
(rpoB gene copy 2.86 (PBS treated) vs 2.84 (LGG treated)
log10 ng/g intestinal sample, p>0.05), nor was a shift in bacte-
rial family composition found (ﬁgure 4). In the LGG treatment
group, a detectable level of LGG was found in three of seven
mouse ileums at 12 h after the third daily gavage.
The increased crypt survival seen with the administration of LGG
is dependent on TLR-2, MyD88 and COX-2 signalling
Having found that administration of LGG to WT mice results in
diminished radiation-induced apoptosis and increased crypt
survival, we next sought to deﬁne a signalling pathway for these
effects. Mice lacking MyD88 signalling exhibited similar baseline
apoptosis to WT mice, but modestly higher crypt survival.
Administration of LGG or LGG-CM to MyD88
 /  mice had no
effect on either crypt survival or apoptosis (ﬁgure 5A,B). This
suggests that the radioprotective effects of LGG in WT mice are
mediated through a MyD88-dependent mechanism. Lactobacilli
are Gram-positive bacteria exhibiting a cell well containing
lipoteichoic acid, but lacking ﬂagella or LPS. Thus we chose to
investigate whether TLR-2 was involved in Lactobacillus-medi-
ated radioprotection. In TLR-2
 /  mice, prophylactic LGG
treatment offered no reduction in epithelial cell positional
apoptosis or improvement in crypt survival, suggesting that the
radioprotective effects of LGG in WT mice are mediated through
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Figure 3 Lactobacillus rhamnosus GG (LGG) pretreatment improves
outcomes of radiation-induced gastrointestinal syndrome. Mice received
3 days of oral gavage with phosphate-buffered saline (PBS) or LGG
before 12 Gy whole body irradiation, after which no further treatment
was given. Mice were followed for weight loss (A) and survival (B).
Intestinal tissues harvested from a similar experiment at 7 days were
ﬁxed as longitudinal sections and evaluated for histological changes.
Representative images from the proximal jejunum and terminal ileum are
shown at 2003 (C). The number of intact villi were counted from on four
ﬁelds (1003) from each mouse and are shown for both the ileum and
jejunum (D). Weight loss and villi counts, n¼5/group in each of two
separate experiments. Survival, n¼10/group in each of two separate
experiments. *p<0.05, **p<0.01, ***p<0.001 vs PBS.
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Figure 4 Effect of Lactobacillus rhamnosus GG (LGG) oral inoculation
on bacterial families in the mouse ileum. Mice were gavaged with
phosphate-buffered saline (PBS) or LGG for three consecutive days and
killed at 12 h after the last gavage. Bacterial densities of distal ileal
intestinal contents with mucosal scrapings were examined using LGG
and family-speciﬁc quantitative PCR (qPCR) assays. Data depict relative
density of each bacterial family as measured by qPCR and DNA standard
curves. Data were log10 normalised before statistical analysis was
performed. No statistically signiﬁcant changes were noted in bacterial
families (p>0.05) after LGG treatment. N¼7 per group. LGG was
detected in 0% of PBS-treated mice and 43% of LGG-treated mice.
Lachno-Rumino, LachnospiraceaeeRuminococcaceae; UDL, under
detection limit (1.38 pg DNA/ml).
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ProbioticsTLR-2 (ﬁgure 5C,D). As a negative control, we examined the
speciﬁcity of the TLR-2/MyD88 pathway by conﬁrming
the presence of LGG-mediated intestinal radioprotection in
TLR-4
 /  mice (mean crypt survival/jejunal cross-section
13.262.1 vs 22.663.1 for PBS vs LGG; p¼0.02). We suspected
that TLR-4 signalling would not play a role in the radioprotec-
tive effects of LGG because LGG is a Gram-positive organism
and does not make LPS.
We have previously demonstrated that the radioprotective
effects of LPS are mediated through the induction of COX-2
expression and the synthesis of PGE2.
10 We sought to determine
if this pathway is involved in the radioprotective effects of LGG.
At baseline, radiation-induced apoptosis in mice with disrupted
COX-2 was modestly diminished compared with WT mice
(ﬁgure 5E). The administration of LGG to COX-2
 /  mice
resulted in a small but signiﬁcant further decrease in apoptosis
only at position 5 (from 28% to 22%), a reduction less striking
than that seen in the WT mice. Baseline crypt survival after
radiation in COX-2
 /  mice was similar to that seen in WT
mice, and administration of LGG to COX-2
 /  mice did not
improve crypt survival (ﬁgure 5F). These results suggest that the
radioprotective effects of LGG on crypt survival are mediated at
least in part through COX-2.
Having found that signalling through COX-2 is important to
the radioprotective effects of LGG, we next sought to determine
if administration of LGG resulted in an increase in COX-2
expression. Administration of LGG by gavage did not result in
increases in intestinal COX-2 mRNA or intestinal PGE2 levels
(ﬁgure 6A,B). We previously demonstrated that in DSS-induced
colitis, COX-2-expressing MSCs in the distal colon migrate from
positions in the lamina propria that are adjacent to the upper
parts of the crypts to positions in the lamina propria adjacent to
the more rapidly proliferating epithelial cells in the lower
crypts.
4 In light of this observation, we sought to determine if
the administration of LGG resulted in the migration of COX-2-
expressing cells in the small intestine. Since the effect of LGG
was prophylactic in preventing injury, we examined unirradiated
mice for this shift. The LGG dosing schedule used here was the
same as that used to demonstrate radioprotection. While there
was no difference in the number of COX-2-expressing stromal
cells after LGG, there was a shift in cell localisation from the villi
to the crypt region (ﬁgure 6C,D). In PBS-gavaged mice, we found
80% of COX-2-expressing cells in the lamina propria of the villi,
with 20% residing in the lamina propria surrounding the crypts.
After LGG, however, 62% of the COX-2-expressing cells were
associated with the villi, and 38% were in the crypt region
(ﬁgure 6E). Thus we observed a highly signiﬁcant (p<0.001)
shift in COX-2-expressing cells from the villi to the crypt region
after LGG exposure in WT mice. In TLR-2
 /  mice gavaged with
LGG, no shift in COX-2-expressing cells occurred (p¼0.34). At
baseline, TLR-2
 /  mice exhibited a greater proportion of COX-
2-expressing cells already in the crypt region. Overall these
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Figure 5 Radioprotective effects of Lactobacillus rhamnosus GG (LGG)
require TLR-2/MyD88 signalling and cyclo-oxygenase 2 (COX-2). (A) In
MyD88
 /  mice, the intestinal epithelial cell apoptotic index curves at
6 h showed no signiﬁcant difference between mice treated with
phosphate-buffered saline (PBS) or live LGG for 3 days before radiation
(n¼6/group). (B) MyD88
 /  mice showed no change in crypt survival
after gavage with LGG or LGG conditioned medium (LGG-CM) when
compared with PBS or media controls (n>10 total/group over two or
more experiments). (C) TLR-2
 /  mice exhibit similar epithelial crypt
apoptosis index with LGG treatment to PBS (n¼4/group). (D) Crypt
survival is not improved by LGG in TLR-2
 /  mice (n¼9/group over two
separate experiments). (E) COX-2
 /  mice were evaluated for
apopotosis (n¼7/group) and (F) surviving crypts (n¼9/group). FSC,
forward scatter. *p#0.05 vs LGG.
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Probioticsﬁndings support the feasible link between LGG, TLR-2 signalling
and COX-2-dependent radioprotection.
We next sought to further characterise the identiﬁed COX-2-
positive cells of the lamina propria. By immunoﬂuorescence,
most of the COX-2-positive cells were CD44 positive and many
were positive for CD29 and CD106 (ﬁgure 7A). This pattern of
expression is consistent with these COX-2-positive cells being
MSCs. We had previously demonstrated that colonic MSCs had
high levels of COX-2 expression.
31 We now isolated small
intestinal MSCs and found that they also had high levels of
COX-2 expression (ﬁgure 7B) and by ﬂow cytometry were
positive for MSC markers CD29, CD44 and CD106, and nega-
tive for cell surface markers CD45 (haematopoietic), F4/80
(macrophage) and PECAM (endothelial) (ﬁgure 7C). qRT-PCR
was used to identify TLR expression on these MSCs, with TLRs
2, 3, 4 and 5 showing the highest expression levels (ﬁgure 7D).
No PCR product was observed on gel electrophoresis for murine
TLR-13. In vitro exposure of the MSCs to a TLR-2 ligand
resulted in increased tumour necrosis factor a and COX-2
mRNA, demonstrating functional relevance to the TLR-2
expression (ﬁgure 7E).
DISCUSSION
Administration of probiotic Lactobacillus spp. before irradiation
results in decreased epithelial apoptosis and increased crypt
survival in the mouse small intestine. In this study, the greatest
protection was offered by administration of LGG, although
gavage with other Lactobacillus spp. or LGG-CM also showed
signiﬁcant beneﬁt. Administration of a Biﬁdobacterium sp. was not
radioprotective in this model. The radioprotective effects mediated
by LGG required intact signalling of TLR-2, MyD88 and COX-2.
LGG was protective when given before, but not after, radiation,
suggesting that LGG acts by preventing radiation-induced injury
rather than enhancing repair.
Peptidoglycan and lipoteichoic acid, components of the cell
wall of Gram-positive bacteria including LGG, are TLR-2 ligands.
The ﬁnding that LGG-CM is also radioprotective suggests that
LGG peptidoglycan or lipoteichoic acid is released into the
medium and is capable of binding TLR-2. This is the ﬁrst
demonstration that a probiotic-based biological effect is medi-
ated through TLR-2. The only previous demonstration of the
beneﬁcial effects of a probiotic being mediated through TLR
signalling was the report that anti-inﬂammatory effects of
VSL#3, a mixture of different bacteria, are mediated through
TLR-9.
39 Heat shock proteins, reactive oxygen species and AKT
activation have all been implicated in mediating the biological
effects of LGG.
18 30 40 Whether TLR-2 activation is also involved
in mediating these effects has not been addressed. The positional
curves for radiation-induced apoptosis were different in the
TLR-2
 /  and MyD88
 /  mice, raising the possibility that other
TLRs may also play a role in the host response to radiation.
Yan et al described two novel proteins secreted by LGG, p40
and p75, that induce AKTactivation and inhibit tumour necrosis
factor-induced apoptosis in human and mouse epithelial cell
lines and in mouse colonic explants.
17 30 While it is possible that
these proteins contribute to radioprotection, it is unlikely that
one or both of these proteins is solely responsible for the
decrease in radiation-induced apoptosis and increased crypt
survival induced by LGG. The radioprotective effects seen with
LGG are mediated by MyD88 and COX-2. The role of TLRs and
COX-2 in mediating the effects of p40 and p75 has not been
addressed. However, it was observed that the p40 and p75
proteins were expressed and cytokine protection was exhibited
by both LGG and L casei, although not by L acidophilus.I n
contrast, L acidophilus was effective at reducing radiation-
induced epithelial injury in the present study. The explanation
for possible genus speciﬁcity for lactobacilli in radioprotection is
not known. While biﬁdobacteria are also Gram-positive bacteria,
the species we tested was not radioprotective. LGG-CM is
protective and the radioprotective effects of LGG are TLR-2
dependent. This suggests that LGG may release a TLR-2 ligand
into the medium. The failure of biﬁdobacterium, another Gram-
positive bacterium, may be related to the failure to release
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Figure 6 Lactobacillus rhamnosus GG (LGG) shifts prostaglandin-
producing cells. Wild-type mice received 3 days of gavaging with
phosphate-buffered saline (PBS) or LGG, and proximal to mid jejunal
tissues were harvested for analysis. (A) Relative expression of cyclo-
oxygenase 2 (COX-2) mRNA measured by quantitative reverse
transcription-PCR. (B) ELISA analysis of prostaglandin 2 (PGE2)
production. (C) Total number of COX-2-expressing cells per 2003 ﬁeld.
(D) Immunoﬂuorescence showing COX-2-expressing cells within the
crypt/villus structure. The crypt/villus junction is demarcated by a yellow
dotted line (2003). (E) Position of COX-2-positive cells in relation to
crypt/villus junction expressed as percentage of total COX-2-positive
cells in wild-type and TLR-2
 /  (TLR2 KO) mice. N¼5 mice per group/
experiment; experiment completed twice.
Gut 2012;61:829e838. doi:10.1136/gutjnl-2011-300367 835
Probioticsa TLR-2 ligand, adherence properties, differential positioning of
the bacterium with respect to the intestinal epithelium and the
mucous layer, or differential signalling by its lipoteichoic acid-
based outer membrane.
41e43 The ﬁnding of differential efﬁcacy
among speciﬁc probiotic species and strains has been reported
for other conditions.
44 Dosage, potency and/or host handling are
other possible explanations for the differences in efﬁcacy.
Radioprotective effects of LGG are mediated through COX-2.
PGE2, which can be produced through either COX-1 or COX-2,
is radioprotective in the intestine.
10 The radioprotective effects
of LPS, acting through TLR-4, are dependent on COX-2 and
PGE2.
10 Parenteral administration of LPS induces increased COX-
2 expression in the intestine. Although LGG also acts through a
COX-2-dependent mechanism, gavage with LGG affected
neither the expression of COX-2 nor the level of PGE2 in the
small intestine. LGG did not affect the total number of COX-2-
expressing cells in the intestine; however, in response to LGG,
the number of COX-2-expressing cells associated with the crypts
increased.
In the normal colon, there is a population of cells in the
lamina propria near the upper crypts that constitutively express
COX-2.
4 These cells also express CD44, CD29, CD105 and
CD106, a pattern consistent with MSCs.
31 In DSS-induced
colitis, there are COX-2-dependent protective effects that
preserve epithelial proliferation, even though DSS-colitis is not
associated with increased COX-2 expression or increased PGE2
production. In the DSS model, COX-2-expressing MSCs
migrated from near the upper crypt epithelium to near the lower
crypt epithelial cells. This process is MyD88 dependent. Our
interpretation of these ﬁndings was that the migration of COX-
2-expressing cells allowed a high concentration of PGE2 in the
area immediately surrounding the proliferating crypt cells and
that PGE2 supported epithelial cell proliferation. In the present
study, we observed a similar pattern now in the small intestine.
The small intestinal MSCs that constitutively express high
levels of COX-2 migrated in response to LGG in a TLR-2-
dependent fashion. The migration of these COX-2-positive cells
was associated with diminished epithelial apoptosis and
increased crypt survival in response to radiation injury.
These migrating cells express COX-2 and surface proteins
associated with MSCs. The constitutive expression of high levels
of COX-2 is speciﬁc to intestinal and colonic MSCs, as bone
marrow-derived MSCs expressed little COX-2 (ﬁgure 6B). The
high level of COX-2 expression in colonic MSCs is not TLR
dependent, but dependent on ﬁbroblast growth factor 9 (FGF9)
produced by epithelial cells.
31 In the present study, the migration
of these intestinal MSCs was found to be TLR-2 speciﬁc. How
TLR-2 signalling is involved in their migration is not clear. It is
possible that the TLR-2 signalling occurs in the MSCs, as these
cells functionally express the gene; however, it also possible that
the TLR-2 ligand binds to a cell in or near the crypt, and this cell
produces a chemotactic factor that promotes the migration of
the MSCs towards the crypt. PGE2 produced by these COX-2-
expressing MSCs would act to protect adjacent epithelial stem
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Figure 7 Characterization of small intestinal cyclo-oxygenase 2 (COX-
2)-positive cells. (A) Immunoﬂuoresence co-staining of jejunal COX-2-
expressing cells and mesenchymal stem cell (MSC) surface markers. (B)
COX-2 quantitative reverse transcription-PCR of small intestinal (SI) and
colonic (C) MSCs relative to bone marrow-derived (BM) MSCs. (C) Flow
cytometry for cell surface markers of isolated COX-2-expressing MSCs.
Gating based on isotype control. (D) mRNA expression of murine TLR
ligands relative to actin (log10) in isolated SI-MSCs. (E) Tumour necrosis
factor (TNF)a and COX-2 mRNA expression in MSCs after stimulation
with a TLR-2 ligand (Pam3CSK4) for 18 h. FSC, forward scatter
*p<0.05, **p<0.01 vs the control (CTRL).
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Probioticscells from radiation-induced apoptosis. The close physical
proximity of the PGE2-producing MSCs and the epithelial stem
cells is important because PGE2 is unstable and therefore only
acts over short distances. We have now demonstrated TLR-
dependent migration of COX-2-positive MSCs as being involved
in DSS-colitis and radioprotective in the small intestine. This
raises the possibility that TLR-dependent migration of COX-2-
expressing MSCs may be a generalised mechanism for epithelial
protection in the intestine and colon.
These studies were carried out using 12 Gy of total body
irradiation, with epithelial apoptosis, crypt survival, weight loss
and duration of survival used as biological end points. This is the
standard protocol for intestinal radioprotection studies in the
mouse. As no animal model exactly mirrors the human disease,
certain distinctions should be noted. Humans undergoing radi-
ation therapy for abdominal malignancy receive lower, frac-
tionated doses of radiation to the intestine. The major clinical
effects in humansddiarrhoea and vomitingdtypically develop
during the second week of radiotherapy (cumulative radiation
dose of 15e20 Gy).
3 Mice do not typically develop diarrhoea or
vomiting in response to radiation but exhibit weight loss and, if
the enterocyte depletion is high, death over the ﬁrst 10 days.
Nonetheless, this study has relevance for radioprotection in
patients in that radiation-induced diarrhoea is a product of
radiation-induced epithelial apoptosis in the intestine, and other
agents that reduce radiation-induced apoptosis are also effective
radioprotective agents.
11 45 Furthermore, agents demonstrated
to be radioprotective in mice using this radiation protocol are
also radioprotective in primates.
11
This study raises the possibility of using probiotics as
radioprotective agents in man and provides insight into the
administrative route, timing and mechanism of probiotic-
mediated intestinal radioprotection. As radioprotectants,
probiotics have the advantage of providing wide luminal
coverage and act locally at the mucosal surface to protect the
normal epithelium without having a systemic distribution.
Although probiotics such as LGG
46 have an excellent human
safety proﬁle, if viable bacteria were used in human trials, close
monitoring would be critical. Further studies directed at
delineating mechanisms and optimising the radioprotective
effects of probiotics are indicated.
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